Page 19 - 2026 SMOG
P. 19

BLOOD AND COMPONENT USE
                IMMEDIATE Indications in Trauma Patients With Serious Injury
         •  Systolic BP <100 or weak/absent radial pulse
         •  Tachycardia >100
         •  Amputation(s), penetrating chest/abdomen injury, truncal/junctional injury
                                 Clinical Indications
         •  Significant trauma
         •  Evidence of hemorrhagic shock
         •  Altered mental status in the absence of brain injury
         •  Severe hypothermia associated with blood loss
         •  Clinical signs of coagulopathy (tachycardia, tachypnea, fever, altered mentation, hypoxemia)
         •  Positive FAST exam (especially if two or more regions are positive)
         •  Lactate >4mmol/L, base deficit >6mEq/L (base excess <–6mEq/L), pH <7.25, INR ≥1.5
                                     Treatment
         •  Maximize hemorrhage control, treatment of suspected tension pneumothorax, patent airway or
           airway control, IV/IO access, hypothermia prevented and/or treated
         •  Blood Product Order of Precedence
              ˚  Whole Blood
              ˚  Plasma, RBCs, Platelets in a 1:1:1 Ratio (no particular order)
              ˚  Plasma and RBCs in a 1:1 Ratio
             Plasma (thawed, liquid, reconstituted) alone or RBCs alone
              ˚
         •  Document all items on the SF 518 (the only authorized document for blood products aboard
           Army aeromedical evacuation platforms)
              ˚  Two-person verification of patient and blood products given matching SF 518
         •  Examine units of blood (look for gas, discoloration, clots, and sediment) and verify that the
           Safe-T-Vue is white
         •  Initiate large-bore IV (18Gmin, 14G preferred) or IO access (Lidocaine 2% (2–3mL) flush in
           IO site provides analgesia and increases compliance)
         •  Blood and blood products must be administered through a Y-tubing with a filter, flushed with
           NS prior to use
         •  Transfuse blood through an approved fluid warming device if available
              ˚  Achieve rapid transfusion via pressure bag up to 300mmHg; use a 60mL syringe or manual
             pressure in the event a pressure infuser is not available
         •  Consider slowing all other concurrent infusions unless they are TXA or RFVIIa
         •  Resuscitation Goal: until palpable radial pulse, improved mental status, or SBP >100
           (>110 with head injury) and MAP >60mmHg
         •  30mL of 10% Calcium Gluconate or 10mL of 10% Calcium Chloride IV/IO should be given to
           patients in hemorrhagic shock during or immediately after transfusion of the first unit of blood
           product and with ongoing resuscitation after every 4 units of blood product. Monitor ionized
           calcium, and administer calcium if ionized calcium levels are less than 1mmol/L
         •  Monitor the patient q5min and document any patient signs and symptoms consistent with
           transfusion reaction (monitor core temperature)
              ˚  If a transfusion reaction occurs, see the TRANSFUSION REACTION PROTOCOL.
         Reference: CPG ID #18 (Damage Control Resuscitation), CPG ID #26 (Frozen and Deglycerolized Red Blood
         Cells), CPG ID #73 (Damage Control Resuscitation – Prolonged Field Care), CPG ID #82 (Prehospital Blood
         Transfusion)


                           2026 Standard Medical Operating Guidelines (SMOG)  •   11
   14   15   16   17   18   19   20   21   22   23   24